Drug-associated Torsades de Pointes and QT prolongation were identified as significant adverse events in infants, indicating potential safety concerns with certain medications.
Which drugs are associated with Torsades de Pointes and QT prolongation in infants?
This pharmacovigilance study identifies critical safety signals for Torsades de Pointes and QT prolongation associated with various drugs in infants, highlighting the need for cautious use and ECG monitoring in this vulnerable population.
Absolute Event Rate: 0% vs 0%
A Focused Real-World Disproportionality Analysis Pharmacovigilance Study.
Sridharan et al. (Sun,) reported a other. Drug-associated Torsades de Pointes and QT prolongation were identified as significant adverse events in infants, indicating potential safety concerns with certain medications.